97 related articles for article (PubMed ID: 10339304)
1. When laboratories go with flow analysis.
Check W
CAP Today; 1998 Nov; 12(11):1, 20, 26 passim. PubMed ID: 10339304
[No Abstract] [Full Text] [Related]
2. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey.
Homburger HA; Rosenstock W; Paxton H; Paton ML; Landay AL
Ann N Y Acad Sci; 1993 Mar; 677():43-9. PubMed ID: 8494233
[No Abstract] [Full Text] [Related]
3. Centers for Disease Control programs in flow cytometric immunophenotyping.
Gerber AR
Ann N Y Acad Sci; 1993 Mar; 677():40-2. PubMed ID: 8388182
[No Abstract] [Full Text] [Related]
4. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
Nicholson JK
Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
[TBL] [Abstract][Full Text] [Related]
5. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing.
Rickman WJ; Monical C; Waxdal MJ
Ann N Y Acad Sci; 1993 Mar; 677():53-8. PubMed ID: 8494246
[No Abstract] [Full Text] [Related]
6. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy.
Brando B; Sommaruga E
Cytometry; 1993; 14(3):294-306. PubMed ID: 8472606
[TBL] [Abstract][Full Text] [Related]
7. Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium.
Finak G; Langweiler M; Jaimes M; Malek M; Taghiyar J; Korin Y; Raddassi K; Devine L; Obermoser G; Pekalski ML; Pontikos N; Diaz A; Heck S; Villanova F; Terrazzini N; Kern F; Qian Y; Stanton R; Wang K; Brandes A; Ramey J; Aghaeepour N; Mosmann T; Scheuermann RH; Reed E; Palucka K; Pascual V; Blomberg BB; Nestle F; Nussenblatt RB; Brinkman RR; Gottardo R; Maecker H; McCoy JP
Sci Rep; 2016 Feb; 6():20686. PubMed ID: 26861911
[TBL] [Abstract][Full Text] [Related]
8. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Kalina T; Flores-Montero J; van der Velden VH; Martin-Ayuso M; Böttcher S; Ritgen M; Almeida J; Lhermitte L; Asnafi V; Mendonça A; de Tute R; Cullen M; Sedek L; Vidriales MB; Pérez JJ; te Marvelde JG; Mejstrikova E; Hrusak O; Szczepański T; van Dongen JJ; Orfao A;
Leukemia; 2012 Sep; 26(9):1986-2010. PubMed ID: 22948490
[TBL] [Abstract][Full Text] [Related]
9. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
Lanza F
Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
[No Abstract] [Full Text] [Related]
10. National external quality assessment scheme for lymphocyte immunophenotyping in Belgium.
Van Blerk M; Bernier M; Bossuyt X; Chatelain B; D'Hautcourt JL; Demanet C; Kestens L; Van Bockstaele D; Crucitti T; Libeer JC
Clin Chem Lab Med; 2003 Mar; 41(3):323-30. PubMed ID: 12705342
[TBL] [Abstract][Full Text] [Related]
11. Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.
Lacombe F; Bernal E; Bloxham D; Couzens S; Porta MG; Johansson U; Kern W; Macey M; Matthes T; Morilla R; Paiva A; Palacio C; Preijers F; Ratei R; Siitonen S; Allou K; Porwit A; Béné MC
Leukemia; 2016 Aug; 30(8):1769-72. PubMed ID: 26922887
[No Abstract] [Full Text] [Related]
12. Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines?
Basso G; Lanza F; Orfao A; Benè M; Borowitz M; Campana D; Lacombe F; Ludwig WD; Porwitt-MacDonald A; Rothe G; Dworzac M;
J Biol Regul Homeost Agents; 2002; 16(4):257-8. PubMed ID: 12597641
[No Abstract] [Full Text] [Related]
13. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
Davis BH; Foucar K; Szczarkowski W; Ball E; Witzig T; Foon KA; Wells D; Kotylo P; Johnson R; Hanson C; Bessman D
Cytometry; 1997 Oct; 30(5):249-63. PubMed ID: 9383099
[No Abstract] [Full Text] [Related]
14. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
[TBL] [Abstract][Full Text] [Related]
15. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting.
Braylan RC; Atwater SK; Diamond L; Hassett JM; Johnson M; Kidd PG; Leith C; Nguyen D
Cytometry; 1997 Oct; 30(5):245-8. PubMed ID: 9383098
[No Abstract] [Full Text] [Related]
16. Setting up and calibration of a flow cytometer for multicolor immunophenotyping.
Kraan J; Gratama JW; Keeney M; D'Hautcourt JL
J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607
[No Abstract] [Full Text] [Related]
17. Toward a worldwide standard for CD34+ enumeration?
Johnsen HE
J Hematother; 1997 Apr; 6(2):83-9. PubMed ID: 9131436
[No Abstract] [Full Text] [Related]
18. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, Maryland, November 16-17, 1995.
Cytometry; 1997 Oct; 30(5):213-74. PubMed ID: 9383094
[No Abstract] [Full Text] [Related]
19. External quality assessment in clinical cell analysis by flow cytometry. Why is it so important?
Siftar Z; Paro MM; Sokolić I; Nazor A; Mestrić ZF
Coll Antropol; 2010 Mar; 34(1):207-17. PubMed ID: 20432753
[TBL] [Abstract][Full Text] [Related]
20. Standardized Multi-Color Flow Cytometry and Computational Biomarker Discovery.
Schlickeiser S; Streitz M; Sawitzki B
Methods Mol Biol; 2016; 1371():225-38. PubMed ID: 26530805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
